PL350520A1 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- PL350520A1 PL350520A1 PL00350520A PL35052000A PL350520A1 PL 350520 A1 PL350520 A1 PL 350520A1 PL 00350520 A PL00350520 A PL 00350520A PL 35052000 A PL35052000 A PL 35052000A PL 350520 A1 PL350520 A1 PL 350520A1
- Authority
- PL
- Poland
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO990814A NO309305B1 (no) | 1999-02-19 | 1999-02-19 | Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater |
| PCT/NO2000/000060 WO2000048610A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL350520A1 true PL350520A1 (en) | 2002-12-16 |
Family
ID=19902986
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL00350520A PL350520A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
| PL00350519A PL350519A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL00350519A PL350519A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP1150689A1 (xx) |
| JP (2) | JP2002537264A (xx) |
| CN (2) | CN1347323A (xx) |
| AU (2) | AU2834100A (xx) |
| BR (2) | BR0008302A (xx) |
| CA (2) | CA2362306A1 (xx) |
| CZ (2) | CZ20012966A3 (xx) |
| HU (2) | HUP0105281A2 (xx) |
| IL (2) | IL144896A0 (xx) |
| MX (2) | MXPA01008347A (xx) |
| NO (1) | NO309305B1 (xx) |
| PL (2) | PL350520A1 (xx) |
| RU (2) | RU2001123124A (xx) |
| SK (2) | SK11602001A3 (xx) |
| WO (2) | WO2000048610A1 (xx) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4182218B2 (ja) * | 2001-05-30 | 2008-11-19 | 学校法人東京理科大学 | アポトーシスを誘導する新規なグルコース誘導体、その製造方法及び医薬としてのその用途 |
| DE10261807A1 (de) | 2002-12-19 | 2004-07-01 | Turicum Drug Development Ag | Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel |
| WO2007012650A1 (en) * | 2005-07-26 | 2007-02-01 | Nycomed Gmbh | Isotopically substituted proton pump inhibitors |
| CA2615678C (en) * | 2005-07-26 | 2015-01-20 | Nycomed Gmbh | Isotopically substituted pantoprazole |
| EP1934201A1 (en) * | 2005-10-06 | 2008-06-25 | Auspex Pharmaceuticals Inc. | Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
| CN101157711B (zh) * | 2007-09-28 | 2010-12-08 | 西安交通大学 | 一种具有抗肿瘤活性的化合物及其用途 |
| JP2011516478A (ja) * | 2008-04-03 | 2011-05-26 | コグネイト ３，エルエルシー | 免疫療法のための組成物および方法 |
| CN101735284B (zh) * | 2008-11-24 | 2012-05-23 | 上海医药工业研究院 | 一种4,6-o-苄叉-d-吡喃葡萄糖的制备方法 |
| WO2015085004A1 (en) | 2013-12-03 | 2015-06-11 | Intra-Cellular Therapies, Inc. | Novel methods |
| PL3125893T3 (pl) | 2014-04-04 | 2024-02-12 | Intra-Cellular Therapies, Inc. | Deuterowane gamma-karboliny w fuzji z heterocyklami jako antagoniści receptorów 5-HT2A |
| JP6898072B2 (ja) * | 2015-08-27 | 2021-07-07 | 秀行 佐谷 | １４−３−３タンパク質活性調節剤 |
| RU2733975C2 (ru) | 2016-03-25 | 2020-10-08 | Интра-Селлулар Терапиз, Инк. | Органические соединения |
| CN110072518B (zh) | 2016-10-12 | 2021-10-26 | 细胞内治疗公司 | 无定形固体分散体 |
| CN110430879B (zh) | 2017-03-24 | 2023-04-21 | 细胞内治疗公司 | 新组合物和方法 |
| KR20210052471A (ko) | 2018-08-31 | 2021-05-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
| MX2021002321A (es) | 2018-08-31 | 2021-04-28 | Intra Cellular Therapies Inc | Nuevos metodos. |
| CN114072150A (zh) | 2019-07-07 | 2022-02-18 | 细胞内治疗公司 | 新方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB811510A (en) * | 1954-12-20 | 1959-04-08 | Gyogyszeripari Ki | New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof |
| JPS6112623A (ja) * | 1984-06-28 | 1986-01-21 | Kaken Pharmaceut Co Ltd | エンケフアリナ−ゼ阻害剤 |
| JPS6256423A (ja) * | 1985-09-06 | 1987-03-12 | Kaken Pharmaceut Co Ltd | 悪液質治療改善剤 |
| GB8705780D0 (en) * | 1987-03-11 | 1987-04-15 | Norsk Hydro As | Anticancer compounds |
| JPH07145191A (ja) * | 1993-11-24 | 1995-06-06 | Japan Tobacco Inc | ガラクトシルホスフォネート誘導体 |
-
1999
- 1999-02-19 NO NO990814A patent/NO309305B1/no not_active IP Right Cessation
-
2000
- 2000-02-18 WO PCT/NO2000/000060 patent/WO2000048610A1/en not_active Application Discontinuation
- 2000-02-18 PL PL00350520A patent/PL350520A1/xx not_active Application Discontinuation
- 2000-02-18 IL IL14489600A patent/IL144896A0/xx unknown
- 2000-02-18 EP EP00906781A patent/EP1150689A1/en not_active Withdrawn
- 2000-02-18 CN CN00806488A patent/CN1347323A/zh active Pending
- 2000-02-18 JP JP2000599401A patent/JP2002537264A/ja active Pending
- 2000-02-18 CN CN00806338A patent/CN1347322A/zh active Pending
- 2000-02-18 CZ CZ20012966A patent/CZ20012966A3/cs unknown
- 2000-02-18 RU RU2001123124/15A patent/RU2001123124A/ru unknown
- 2000-02-18 AU AU28341/00A patent/AU2834100A/en not_active Abandoned
- 2000-02-18 CA CA002362306A patent/CA2362306A1/en not_active Abandoned
- 2000-02-18 IL IL14489500A patent/IL144895A0/xx unknown
- 2000-02-18 SK SK1160-2001A patent/SK11602001A3/sk unknown
- 2000-02-18 BR BR0008302-0A patent/BR0008302A/pt not_active Application Discontinuation
- 2000-02-18 HU HU0105281A patent/HUP0105281A2/hu unknown
- 2000-02-18 AU AU28342/00A patent/AU2834200A/en not_active Abandoned
- 2000-02-18 HU HU0105280A patent/HUP0105280A2/hu unknown
- 2000-02-18 SK SK1161-2001A patent/SK11612001A3/sk unknown
- 2000-02-18 CZ CZ20012965A patent/CZ20012965A3/cs unknown
- 2000-02-18 EP EP00906782A patent/EP1150690A1/en not_active Withdrawn
- 2000-02-18 RU RU2001123035/14A patent/RU2001123035A/ru unknown
- 2000-02-18 WO PCT/NO2000/000059 patent/WO2000048609A1/en not_active Application Discontinuation
- 2000-02-18 PL PL00350519A patent/PL350519A1/xx not_active Application Discontinuation
- 2000-02-18 MX MXPA01008347A patent/MXPA01008347A/es not_active Application Discontinuation
- 2000-02-18 BR BR0008297-0A patent/BR0008297A/pt not_active Application Discontinuation
- 2000-02-18 CA CA002363670A patent/CA2363670A1/en not_active Abandoned
- 2000-02-18 MX MXPA01008346A patent/MXPA01008346A/es not_active Application Discontinuation
- 2000-02-18 JP JP2000599400A patent/JP2002537263A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2001123035A (ru) | 2004-03-20 |
| IL144896A0 (en) | 2002-06-30 |
| JP2002537263A (ja) | 2002-11-05 |
| CZ20012966A3 (cs) | 2002-03-13 |
| HUP0105281A2 (hu) | 2002-05-29 |
| HUP0105280A2 (hu) | 2002-04-29 |
| AU2834100A (en) | 2000-09-04 |
| MXPA01008346A (es) | 2003-06-06 |
| CA2363670A1 (en) | 2000-08-24 |
| CN1347323A (zh) | 2002-05-01 |
| PL350519A1 (en) | 2002-12-16 |
| BR0008297A (pt) | 2002-05-28 |
| SK11602001A3 (sk) | 2002-02-05 |
| NO990814D0 (no) | 1999-02-19 |
| WO2000048610A1 (en) | 2000-08-24 |
| AU2834200A (en) | 2000-09-04 |
| EP1150689A1 (en) | 2001-11-07 |
| EP1150690A1 (en) | 2001-11-07 |
| MXPA01008347A (es) | 2004-03-10 |
| RU2001123124A (ru) | 2004-02-20 |
| SK11612001A3 (sk) | 2002-04-04 |
| CN1347322A (zh) | 2002-05-01 |
| IL144895A0 (en) | 2002-06-30 |
| NO309305B1 (no) | 2001-01-15 |
| JP2002537264A (ja) | 2002-11-05 |
| CA2362306A1 (en) | 2000-08-24 |
| NO990814L (no) | 2000-08-21 |
| CZ20012965A3 (cs) | 2002-03-13 |
| BR0008302A (pt) | 2002-08-27 |
| WO2000048609A1 (en) | 2000-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9907658D0 (en) | Chemical compounds | |
| GB9902461D0 (en) | Chemical compounds | |
| GB9909409D0 (en) | Chemical compounds | |
| PL350519A1 (en) | Chemical compounds | |
| GB9903861D0 (en) | Chemical compounds | |
| GB9910104D0 (en) | Chemical compounds | |
| GB9910110D0 (en) | Chemical compounds | |
| GB9914025D0 (en) | Chemical compounds | |
| GB9900078D0 (en) | Chemical compounds | |
| GB9910394D0 (en) | Chemical compounds | |
| GB9914015D0 (en) | Chemical compounds | |
| GB9914024D0 (en) | Chemical compounds | |
| GB9910419D0 (en) | Chemical compounds | |
| GB9914022D0 (en) | Chemical compounds | |
| GB9908355D0 (en) | Chemical compounds | |
| GB9909062D0 (en) | Chemical compounds | |
| GB9903859D0 (en) | Chemical compounds | |
| GB9906564D0 (en) | Chemical compounds | |
| GB9906565D0 (en) | Chemical compounds | |
| GB9907653D0 (en) | Chemical compounds | |
| GB9907656D0 (en) | Chemical compounds | |
| GB9907657D0 (en) | Chemical compounds | |
| GB9905462D0 (en) | Chemical compounds | |
| GB9905078D0 (en) | Chemical compounds | |
| GB9910421D0 (en) | Chemical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |